Moneycontrol PRO
HomeNewsTrendsHealthCoronavirus pandemic | Poor hygiene, unsanitary conditions may have made Indians more immune to COVID-19

Coronavirus pandemic | Poor hygiene, unsanitary conditions may have made Indians more immune to COVID-19

India's COVID-19 case fatality rate (CFR) of less than two percent is one of the lowest in the world.

November 02, 2020 / 15:21 IST

India has one-sixth of the total coronavirus caseload globally. However, the corresponding death toll of less than two percent, which is one of the lowest in the world. An explanation for this was provided by a research recently conducted by Indian scientists.

The study suggested poor hygiene, lack of clean drinking water, and unsanitary conditions might have kept Indians from contracting severe COVID-19 infections. This means, people living in low and lower middle-income nations may be more immune to COVID-19 and other infections because of their sustained exposure to multiple pathogens since birth.

One paper that remains to be peer reviewed looked at data available in the public domain of 106 countries and compared them based on 24 parameters including population density, demography, and quality of sanitation. The researchers involved with the study found that COVID-19 deaths were higher in high income countries.

According to a BBC report, epidemiologists have also attributed the low coronavirus death rate in countries such as India to its demography – that is higher share of young population – as the elderly are more prone to dying of the viral disease.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Follow our coverage of the coronavirus crisis here

As of November 1, Rajasthan reported 1,754 new cases of the novel coronavirus, taking its tally to 1,98,747. With over 16.83 lakh cases, Maharashtra's COVID-19 tally remains the highest among Indian states and union territories, according to the Union Health Ministry's latest update.

India has recorded more than 82.2 lakh cases of the novel coronavirus and 1.2 lakh deaths. Of these, more than 5.6 lakh are active cases while over 75.4 lakh have recovered.

Across the country, 8.5 lakh samples were tested for the novel coronavirus on November 1, the Indian Council of Medical Research (ICMR) said.

Moneycontrol News
first published: Nov 2, 2020 03:21 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347